Meiact



Indications and Reactions:

Role Indications Reactions
Primary
Sinusitis 50.0%
Product Used For Unknown Indication 25.0%
Upper Respiratory Tract Inflammation 25.0%
Agranulocytosis 25.0%
Tendon Rupture 25.0%
Unresponsive To Stimuli 25.0%
Vomiting 25.0%
Secondary
Nasopharyngitis 16.5%
Drug Use For Unknown Indication 14.8%
Drug Eruption 6.7%
Otitis Media Acute 6.4%
Pharyngitis 6.4%
Gastritis 5.3%
Hypertension 4.5%
Upper Respiratory Tract Inflammation 4.5%
Antipyresis 4.2%
Influenza 4.2%
Diabetes Mellitus 3.4%
Pneumonia Bacterial 3.4%
Prophylaxis 3.4%
Multiple Myeloma 2.8%
Otitis Media 2.8%
Product Used For Unknown Indication 2.8%
Emphysema 2.2%
Rhinitis 2.2%
Arthritis 2.0%
Inappropriate Antidiuretic Hormone Secretion 1.7%
Rash 11.3%
Renal Failure 9.9%
Abnormal Behaviour 8.5%
Stomatitis 8.5%
Interstitial Lung Disease 7.0%
Liver Disorder 5.6%
Renal Failure Acute 5.6%
Tubulointerstitial Nephritis 5.6%
Platelet Count Decreased 4.2%
Pseudomembranous Colitis 4.2%
Rhabdomyolysis 4.2%
Anaphylactic Reaction 2.8%
Intentional Drug Misuse 2.8%
Melaena 2.8%
Mixed Liver Injury 2.8%
Nightmare 2.8%
Pelvic Venous Thrombosis 2.8%
Pyrexia 2.8%
Rash Pruritic 2.8%
Restlessness 2.8%
Concomitant
Asthma 24.5%
Bronchitis 9.8%
Pneumonia 9.6%
Otitis Media 9.4%
Upper Respiratory Tract Inflammation 8.0%
Tonsillitis 6.4%
Conjunctivitis 3.7%
Prophylaxis Against Dehydration 3.7%
Pseudocroup 3.7%
Pyrexia 2.1%
Pharyngitis 2.0%
Diarrhoea 2.0%
Reflux Oesophagitis 2.0%
Dehydration 1.9%
Rhinitis Allergic 1.9%
Otitis Media Acute 1.9%
Rhinitis 1.9%
Prophylaxis Against Diarrhoea 1.9%
Chronic Sinusitis 1.9%
Enterocolitis 1.9%
Acute Tonsillitis 17.3%
Rhinitis 17.3%
Sinusitis 17.3%
Upper Respiratory Tract Inflammation 9.6%
White Blood Cell Count Increased 4.6%
Vomiting 3.8%
White Blood Cell Count Decreased 3.8%
Interstitial Lung Disease 3.1%
Liver Disorder 3.1%
Pyrexia 2.7%
Bipolar Disorder 1.9%
Drug Eruption 1.9%
Hallucination 1.9%
Pancytopenia 1.9%
Rash 1.9%
Erythema Nodosum 1.5%
Incontinence 1.5%
Iron Deficiency Anaemia 1.5%
Lacunar Infarction 1.5%
Lung Neoplasm Malignant 1.5%